PH12016502322B1 - Compounds and methods for preventing or treating malaria - Google Patents
Compounds and methods for preventing or treating malariaInfo
- Publication number
- PH12016502322B1 PH12016502322B1 PH12016502322A PH12016502322A PH12016502322B1 PH 12016502322 B1 PH12016502322 B1 PH 12016502322B1 PH 12016502322 A PH12016502322 A PH 12016502322A PH 12016502322 A PH12016502322 A PH 12016502322A PH 12016502322 B1 PH12016502322 B1 PH 12016502322B1
- Authority
- PH
- Philippines
- Prior art keywords
- methods
- compounds
- preventing
- treating malaria
- malaria
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 241000224016 Plasmodium Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2142CH2014 | 2014-04-28 | ||
| PCT/EP2015/056496 WO2015165660A1 (en) | 2014-04-28 | 2015-03-26 | Triaminopyrimidine compounds useful for preventing or treating malaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12016502322A1 PH12016502322A1 (en) | 2017-01-30 |
| PH12016502322B1 true PH12016502322B1 (en) | 2022-03-23 |
Family
ID=52779638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12016502322A PH12016502322B1 (en) | 2014-04-28 | 2016-11-22 | Compounds and methods for preventing or treating malaria |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9957253B2 (https=) |
| EP (1) | EP3137455B1 (https=) |
| JP (1) | JP6529983B2 (https=) |
| CN (1) | CN106255685B (https=) |
| AP (1) | AP2016009570A0 (https=) |
| BR (1) | BR112016024467B1 (https=) |
| CA (1) | CA2946654C (https=) |
| CY (1) | CY1120700T1 (https=) |
| DK (1) | DK3137455T3 (https=) |
| ES (1) | ES2696350T3 (https=) |
| HR (1) | HRP20181816T1 (https=) |
| HU (1) | HUE042043T2 (https=) |
| LT (1) | LT3137455T (https=) |
| MX (1) | MX374458B (https=) |
| MY (1) | MY178971A (https=) |
| PH (1) | PH12016502322B1 (https=) |
| PL (1) | PL3137455T3 (https=) |
| PT (1) | PT3137455T (https=) |
| RS (1) | RS58124B1 (https=) |
| SI (1) | SI3137455T1 (https=) |
| SM (1) | SMT201800588T1 (https=) |
| WO (1) | WO2015165660A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105699584B (zh) * | 2016-02-03 | 2018-02-09 | 昆药集团股份有限公司 | 一种蒿甲醚相关物质的检测方法 |
| WO2018079629A1 (ja) | 2016-10-26 | 2018-05-03 | カルナバイオサイエンス株式会社 | 抗マラリア活性を有する新規ピリミジン誘導体 |
| CN106727584A (zh) * | 2017-02-08 | 2017-05-31 | 于贵庆 | 一种治疗骨病的药物组合物 |
| JP2020532513A (ja) * | 2017-09-05 | 2020-11-12 | カディラ ヘルスケア リミティド | トリアミノピリミジン化合物およびその中間体の調製方法 |
| CN117327007B (zh) * | 2023-09-26 | 2024-09-13 | 上海陶术生物科技有限公司 | 一种vt107的制备方法 |
| WO2025115034A1 (en) * | 2023-11-30 | 2025-06-05 | Zydus Lifesciences Limited | A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof |
| EP4574143A1 (en) | 2023-12-21 | 2025-06-25 | Universität Regensburg | Inhibitors of plasmodia remodeling enzymes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003286711A1 (en) * | 2002-10-25 | 2004-05-13 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| RU2405778C2 (ru) * | 2004-09-30 | 2010-12-10 | Тиботек Фармасьютикалз Лтд. | 5-гетероциклилпиримидины, ингибирующие вич |
| WO2014058685A1 (en) * | 2012-10-08 | 2014-04-17 | Merck Sharp & Dohme Corp. | Inhibitors of irak4 activity |
-
2015
- 2015-03-26 EP EP15713170.7A patent/EP3137455B1/en active Active
- 2015-03-26 DK DK15713170.7T patent/DK3137455T3/en active
- 2015-03-26 HU HUE15713170A patent/HUE042043T2/hu unknown
- 2015-03-26 CN CN201580022719.8A patent/CN106255685B/zh active Active
- 2015-03-26 JP JP2016562579A patent/JP6529983B2/ja active Active
- 2015-03-26 BR BR112016024467-2A patent/BR112016024467B1/pt active IP Right Grant
- 2015-03-26 MX MX2016014166A patent/MX374458B/es active IP Right Grant
- 2015-03-26 AP AP2016009570A patent/AP2016009570A0/en unknown
- 2015-03-26 PT PT15713170T patent/PT3137455T/pt unknown
- 2015-03-26 RS RS20181368A patent/RS58124B1/sr unknown
- 2015-03-26 CA CA2946654A patent/CA2946654C/en active Active
- 2015-03-26 ES ES15713170T patent/ES2696350T3/es active Active
- 2015-03-26 PL PL15713170T patent/PL3137455T3/pl unknown
- 2015-03-26 US US15/307,382 patent/US9957253B2/en active Active
- 2015-03-26 SM SM20180588T patent/SMT201800588T1/it unknown
- 2015-03-26 HR HRP20181816TT patent/HRP20181816T1/hr unknown
- 2015-03-26 SI SI201530475T patent/SI3137455T1/sl unknown
- 2015-03-26 MY MYPI2016703966A patent/MY178971A/en unknown
- 2015-03-26 WO PCT/EP2015/056496 patent/WO2015165660A1/en not_active Ceased
- 2015-03-26 LT LTEP15713170.7T patent/LT3137455T/lt unknown
-
2016
- 2016-11-22 PH PH12016502322A patent/PH12016502322B1/en unknown
-
2018
- 2018-09-27 CY CY181100997T patent/CY1120700T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2016009570A0 (en) | 2016-11-30 |
| CA2946654A1 (en) | 2015-11-05 |
| MY178971A (en) | 2020-10-26 |
| CN106255685B (zh) | 2019-08-20 |
| EP3137455A1 (en) | 2017-03-08 |
| CN106255685A (zh) | 2016-12-21 |
| US20170050951A1 (en) | 2017-02-23 |
| RS58124B1 (sr) | 2019-02-28 |
| MX374458B (es) | 2025-03-06 |
| JP2017514804A (ja) | 2017-06-08 |
| PL3137455T3 (pl) | 2019-01-31 |
| MX2016014166A (es) | 2017-02-14 |
| PH12016502322A1 (en) | 2017-01-30 |
| BR112016024467B1 (pt) | 2022-11-29 |
| LT3137455T (lt) | 2018-10-25 |
| CA2946654C (en) | 2022-08-23 |
| EP3137455B1 (en) | 2018-08-15 |
| BR112016024467A2 (pt) | 2017-08-15 |
| WO2015165660A1 (en) | 2015-11-05 |
| HK1231478A1 (en) | 2017-12-22 |
| CY1120700T1 (el) | 2019-12-11 |
| SI3137455T1 (sl) | 2019-01-31 |
| US9957253B2 (en) | 2018-05-01 |
| HRP20181816T1 (hr) | 2018-12-28 |
| PT3137455T (pt) | 2018-11-21 |
| DK3137455T3 (en) | 2018-12-10 |
| SMT201800588T1 (it) | 2019-01-11 |
| JP6529983B2 (ja) | 2019-06-12 |
| ES2696350T3 (es) | 2019-01-15 |
| HUE042043T2 (hu) | 2019-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277069B (en) | Modified aminopurine compounds, their compositions and methods of treatment with them | |
| IL264049A (en) | Compounds, preparations and methods for treating the disease | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| GB2541571A (en) | Pharmaceutical compositions | |
| PH12016502322B1 (en) | Compounds and methods for preventing or treating malaria | |
| MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
| IL246875A0 (en) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease | |
| ZA201702799B (en) | 2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors for treating alzheimer's disease | |
| EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
| MX2017002816A (es) | Derivados de pirazolopiridina y su uso en terapia. | |
| ZA201700416B (en) | Methods for treating or preventing ophthalmological conditions | |
| GEP20196984B (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| IL252197A0 (en) | A method for treating, preventing or reducing the risk of skin infection | |
| MX2017016114A (es) | Metodos para tratar o prevenir una proteopatia. | |
| DE112015002229A5 (de) | Formulierungen zur Behandlung von Hyperthyreose | |
| PT3253406T (pt) | Composições para tratar granulomatose com poliangiite | |
| EA201790851A1 (ru) | Способы предотвращения, уменьшения и лечения макулодистрофии | |
| IL248428A0 (en) | Use of 3,1-propanedisulfonic acid or pharmaceutically acceptable saline to treat sarcoidosis | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| IL247616B (en) | Centrally acting acetylcholinesterase inhibitors for the prevention/or treatment of chemically induced neurodegenerative diseases and their symptoms, and corresponding compositions, uses, methods and kit | |
| MA40574A (fr) | Traitement de maladies fibrotiques | |
| IN2014CH01391A (https=) | ||
| GB2546703A (en) | Compounds | |
| HK1240079A1 (en) | Method for treating hyperhidrosis |